摘要:
A real-time system and method for inserting perspective correct content into an image sequence are presented. The invention inserts the content with the location, size, orientation, shape and occlusion properties that are appropriate for the camera view represented by the image sequence. Both static and dynamic content insert positions are supported. The location, size, orientation and shape of the inserted content are determined independently of the image sequence content. Furthermore, no knowledge of three dimensional real world space locations or real world measurements, as related to the content of the image sequence, is used during the content insert process.
摘要:
Systems and methods for augmenting an image sequence with content are disclosed. A system may include a character generator, a graphics frame buffer and a graphics insertion system. The character generator may generate pixel block content. The graphics frame buffer may be in communication with the character generator and store the pixel block content. The graphics insertion system may be in communication with the first graphics frame buffer. The graphics insertion system may be used to retrieve the pixel block content from the first graphics frame buffer and modify an image sequence with an insert graphic based on the pixel block content.
摘要:
A method for calculating a parameter from an image sequence includes selecting a first frame and a second frame in an image sequence. The image sequence has a frame speed. The image sequence or another image sequence is enhanced using a calculation that considers the frame speed and selected frames. The enhancement may be with text, graphics or both such as those that may present statistics corresponding to an event in the image sequence.
摘要:
A technique includes using a computer agent to observe diagnoses of computer-related incidents. Based on the observation, patterns are identified in the diagnoses, and based at least in part on the patterns, the diagnoses are selectively automated.
摘要:
The present invention concerns a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, where R1-R3 and Y are defined in the description, and its use in the treatment of disorders in which pi3 kinase is implicated.
摘要:
There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
摘要:
The tent frame includes an upper hub with a plurality of ribs intended to extend outwardly and a lower hub having an equal number of stretchers. The ends of the stretchers are pivotally connected to the ribs. As the lower hub moves upwardly, the stretchers force the ribs outwardly to erect the tent. Flexible cords extend down from the upper hub through the lower hub and out apertures in the bottom of the lower hub. Pulling the cords apart from within the tent causes the lower hub to move upwardly toward the upper hub to erect the tent. Alternatively, the cords can be passed around pulleys in the lower hub and upwardly through apertures in the top of the upper hub. Pulling the cords apart from above the tent causes the lower hub to move upwardly toward the upper hub to erect the tent.
摘要:
A compound of formula (I) or stereoisomers or pharmaceutically acceptable salts thereof, and their preparation and use as pharmaceuticals wherein R1, R2 and R3 are as defined herein.
摘要:
Compounds of formula (I) in free or pharmaceutically acceptable salt form, where R1, R2, R3, R4, R5, R6, R7, m, n, w, X, and Y have the meanings as indicated in the specification, are useful for treating conditions mediated by the CRTh2 receptor, especially inflammatory or obstructive airways diseases.
摘要:
The present invention concerns a compound of formula Ia wherein: Ra* is hydrogen or C1-4-alkyl; Rb* is —(C1-C4-alkylene)-Y—C1-4-haloalkyl or —(C1-C4-alkylene)-Y—C1-C4-hydroxyalkyl; Y represents —CONH— or a five membered heteroaryl group. R2* is C1-C4-alkyl or halogen; R3* is halo, —SO2—CH3, —SO2—CF3, carboxy, —CO—NH2, —CO-di(C1-C8-alkyl)amino, or a 5- or 6-membered heterocyclic ring having one or more ring hetero atoms selected from the group consisting of oxygen, nitrogen and sulphur, that ring being optionally substituted by halo, cyano, oxo, hydroxy, carboxy, nitro, C3-C8-cycloalkyl, C1-C8-alkylcarbonyl, C1-C8-alkoxy optionally substituted by aminocarbonyl, or C1-C8-alkyl optionally substituted by hydroxy, C1-C8-alkoxy, C1-C8-alkylamino or di(C1-C8-alkyl)amino; R4* is hydrogen, halo, —SO2—CH3, nitrile, C1-C8-haloalkyl, imidazolyl, C1-C8-alkyl, —NR8*R9*, or —SO2—NR8*R9*; and R5* is hydrogen, halogen or C1-C8-alkyl; R8* and R9* are independently hydrogen, amino, C1-C8-alkylamino, di(C1-C8-alkyl)amino, or CC1-C8-alkyl optionally substituted by hydroxyl; or a pharmaceutically acceptable salt, or solvate thereof, to compositions and use of the compounds in the treatment of diseases ameliorated by inhibition of phosphatidylinositol 3-kinase.